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Purpose: To determine the feasibility of using an accelerometer to characterize physical 
activity patterns (PA) surrounding chronic obstructive pulmonary disease (COPD) exacerbations 
(AECOPD) in patients with COPD for 16 weeks. 
Methods: Patients with COPD (n = 8) wore the RT3®, a triaxial accelerometer (Stayhealthy, 
Monrovia, CA) during waking hours and kept daily symptom diaries. The mean vector magnitude 
unit (VMU) per minute was calculated by dividing the total VMU for the day by the number 
of minutes the device was worn. Descriptive statistics were used and plots were made showing 
PA for each subject with AECOPD markers based on symptom diaries and health resource 
utilization. 
Results: Sample characteristics were: age 71 ± 4; 5 Females; forced expiratory volume in 
one second (FEV1)% predicted: 40% ± 16%; FEV1/forced vital capacity: 45 ± 7; and Medical 
Research Council dyspnea scale: 2.3 ± 0.9. Overall adherence to the monitoring protocol was 
97.6% (Range 92%–100%) while adherence to wearing the device for at least 10 hours per day 
was 91.5% (Range 75%–99%). Mean vector magnitude units per minute was 117.8 ± 47 (Range 
61.4–184.1). Seven exacerbations were captured over a total of 896 person-days of monitoring. 
There were substantial intra-individual ﬂ  uctuations in daily PA during both the stable state and 
with outpatient treated exacerbations. 
Conclusions: Patients with COPD were able to adhere to a 16-week activity monitoring 
protocol and reported a willingness to wear such a device for an extended period of time if the 
data yield important and useful information for themselves and their health provider. Future 
work will need to focus ﬁ  rst, on validating other promising devices that produce higher quality 
PA data and second, replicate this monitoring protocol with a larger sample of COPD patients 
over a longer period. 
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Introduction
Frequent exacerbations of chronic obstructive pulmonary disease (COPD) can lead 
to considerable declines in functioning and increased health care costs (NIH 2003). 
There is no generally accepted deﬁ  nition for acute exacerbations of COPD (AECOPD) 
though most studies use the criteria of worsening symptoms accompanied by a change 
in the medical regimen (Pauwels et al 2004). While the follow-up of patients after 
AECOPD has primarily focused on the resolution of symptoms, improvement in lung 
function and gas exchange, and changes in inﬂ  ammatory biomarkers (Seemungal et al 
2001; Aaron et al 2002), investigations into the precise patterns of physical activity 
recovery following AECOPD have been minimal or notably absent.
Findings from studies that rely on caregiver report or retrospective recall suggest 
that patients have considerable functional impairment after AECOPD, especially those 
episodes that require hospitalizations (Connors et al 1996; Garcia-Aymerich et al 2003). 
Connors and colleagues (1996) found that more than 50% of patients hospitalized for an International Journal of COPD 2006:1(4)  456
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AECOPD continued to require assistance with their activities 
of daily living (ADL) six months after discharge. A lower level 
of self-reported physical activity was strongly associated with 
increased risk of hospital readmissions for an AECOPD in 
one recent prospective study (Garcia-Aymerich et al 2003). 
Qualitative interviews in another study showed that AECOPD 
have a negative impact on ADL in 91% of the sample with 
more than half of these patients stopping activities altogether 
during their AECOPD (Vogelmeier et al 2004).
Electronic devices such as accelerometers are suitable 
for long term monitoring and are capable of detecting and 
recording daily activities that are likely difﬁ  cult for patients 
to recall and quantify with typical self-reports (Matthews et 
al 2002). Accelerometers have been used on a short-term 
basis, anywhere from one (Coronado et al 2003; Behnke 
et al 2005) to ﬁ  ve days (Steele et al 2003; Pitta et al 2005), 
often to validate self-reports of physical activity or pre-
scribed exercise. It is important to note that patients who 
experienced AECOPD have typically been excluded from 
physical activity monitoring studies. Therefore, the purpose 
of this exploratory study was to determine the feasibility and 
acceptability of using an accelerometer device to character-
ize physical activity patterns surrounding outpatient-treated 
acute exacerbations of COPD (AECOPD) over a 4-month 
period.
Methods
Patients who met the following criteria were enrolled: 
1) Moderate to severe stable COPD (forced expiratory 
volume in one second [FEV1]%<50% and FEV1/forced 
vital capacity [FVC]<70%) conﬁ  rmed by spirometry; 2) 
Experienced at least two AECOPD that were treated on 
an outpatient basis in the previous 12 months; 3) Absence 
of illnesses such as bronchiectasis, active malignancies or 
other end stage diseases; 4) Ability to speak, read and write 
English; and 5) No plans to engage in any new physical 
activities over the next 4 months. Subjects were recruited 
directly from an academic medical center and Veteran’s 
Administration chest clinics and referrals from a COPD 
support group. We anticipated that if moderate to severely 
ill patients with COPD who had at least 2 outpatient-
treated AECOPD in the previous 12 months were recruited, 
they would potentially experience at least one AECOPD 
within the 4-month monitoring time frame (Seemungal et 
al 2000; Garcia-Aymerich et al 2003). The study protocol 
was approved by the institutional review board and each 
subject gave informed written consent.
The ﬁ  rst author made visits to subjects’ homes to obtain 
written consent, perform spirometry, administer baseline 
paper-pencil questionnaires, demonstrate appropriate use of 
the activity monitor, and instruct on completion of a daily 
symptom diary. Subjects wore the RT3® tri-axial accelerom-
eter (Stayhealthy, Monrovia, CA, USA) during waking hours 
by clipping the device to the waist area, on the nondominant 
side, upon awakening and removing it when they retired to 
bed for approximately 112 consecutive days. Subjects com-
pleted a daily paper-pencil symptom diary. Two telephone 
calls were made within the ﬁ  rst week to ensure that subjects 
did not have any difﬁ  culty wearing the device. Biweekly 
visits to subjects’ homes or to other mutually agreed places 
were made to obtain symptom diaries, download the physi-
cal activity data to a laptop computer, record health resource 
use, install fresh batteries, and provide a small honorarium. 
Subjects received a brief telephone call on alternate weeks 
to encourage adherence. Data were collected from April 
2004 to May 2005.
The pager-size RT3® measured physical activity in 
three dimensions: anteroposterior, vertical, and medi-
olateral. The device sampled movements at a rate of 10Hz 
and analog-to-digital converted data were recorded every 
second and then summed to produce 1-minute movement 
epochs of vector magnitude units (VMU). An earlier 
model of this device (TriTrac®, Stayhealthy, Monrovia, 
CA, USA) was tested in patients with COPD who partici-
pated in pulmonary rehabilitation and concurrent validity 
was established (Steele et al 2003). We operationally 
deﬁ  ned COPD exacerbations as a sustained worsening of 
at least two major symptoms (dyspnea, sputum volume, 
and sputum purulence) or increase in one major and one 
minor symptom (wheezing, cough, sore throat, and nasal 
discharge/congestion) for at least two consecutive days 
and accompanied by changes in the medical regimen 
(Seemungal et al 2000; Pauwels et al 2004). A prescrip-
tion for or self-directed treatment with a course of oral 
prednisone or antibiotics were considered a change in the 
usual medical regimen. Improvements in symptoms for at 
least 3 consecutive days (“better” rating on the symptom 
diary) indicated the start of recovery. The Medical Re-
search Council (MRC) dyspnea scale (Fletcher et al 1959) 
and the Seattle Obstructive Lung Disease Questionnaire 
(SOLDQ) were administered at baseline (Tu et al 1997). 
Exit interviews were conducted during the ﬁ  nal home visit 
to assess acceptability of the protocol and other difﬁ  culties 
not previously identiﬁ  ed. International Journal of COPD 2006:1(4)  457
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Physical activity data were converted into a Microsoft 
Excel (Microsoft, Redmond, WA, USA) ﬁ  le for data reduc-
tion and analysis. The mean VMU per minute was calculated 
by dividing the total VMU for the day by the number of 
minutes the device was worn. We did not remove time spent 
riding in a motor vehicle since unpublished data showed incon-
sequential differences in mean VMU calculations (Steele pers 
comm). We included data for which subjects wore the devices 
at least 10 waking hours. Adherence data were calculated as 
a percentage of the number of days the device was worn out 
of 112 days. Plots were made of the physical activity data for 
each subject with AECOPD noted on the plots based on the 
symptom diaries and medications used. 
Results
Nine subjects were screened with eight (5 women and 3 men) 
who enrolled and completed the study. Subjects had a mean age 
of 71 ± 4, FEV1% predicted of 40% ± 16%, FEV1/FVC ratio 
of 45 ± 7, and MRC dyspnea score of 2.3 ± 0.9. A majority 
of the subjects were Caucasian (88%), attended at least some 
college (63%), and were retired (88%). Baseline SOLDQ 
scores were 38.8 ± 14.9, 69.6 ± 20.3, 75.0 ± 21.7, and 64.1 
± 10.4 for the physical, emotional functioning, coping skills, 
and treatment satisfaction scales, respectively.
Overall, mean adherence to the 112-day monitoring 
protocol was 97.6% (range 92%–100%) while adherence to 
wearing the device for at least 10 hours per day was slightly 
less at 91.5% (range 75%–99%). There were two incidents of 
battery failure with two different devices; a total of 23 days of 
data were lost. The adherence rate was impressive especially 
in light of the consistent report by subjects that remembering 
to wear the device was most challenging. One subject 
commented, “I would see the pager on my kitchen table and 
would pass by it repeatedly during the day but somehow it 
doesn’t cross my mind to clip it on until later when I all of 
sudden realize that I should be doing that”.
The daily average VMU per minute for the sample was 
117.8 ± 47 (range 61.4–184.1). Seven AECOPD were captured 
over 896 person-days of monitoring. Two subjects experienced 
two AECOPD each and three other subjects each experienced 
one episode. We primarily relied on visual analyses of graphical 
plots since no meaningful statistical analyses could reliably be 
performed on the physical activity data from a relatively few 
number of AECOPD events and with the degree of intra- and 
inter-individual, day-to-day variability that we observed. Data 
for one relatively less disabled 72-year old female subject who 
did not have any AECOPD during the 4 month is shown in 
Figure 1. Figure 2 shows data for a 75-year old male subject 
who had three episodes of greater symptoms than usual and 
one meeting our AECOPD criteria. Similar to the other four 
subjects who experienced at least one AECOPD, there was 
a tendency for decreased activity when increased symptoms 
were logged. However, there were no consistent downward 
trends in activity before, during, or after AECOPD that were 
remarkably different from the day-to-day variability. 
Discussion
This exploratory study showed that patients with COPD were 
willing and able to undergo 4 months of continuous physical 
activity monitoring, the longest recording duration that we 
are aware of in the COPD literature. We found that the RT3® 
device captured substantial intra-individual ﬂ  uctuations in 
daily physical activity. Finally, the preliminary data suggest 
that patients who experienced AECOPD and were treated 
at home did not have noticeable changes in their physi-
cal activity patterns before, during, or after the AECOPD 
episode that was distinguishable from their usual day-to-day 
variability.
Our main goal was to assess if patients with moderate to 
severe COPD would wear an unobtrusive monitoring device 
that could potentially yield useful information about their 
health over an extended period. The overall adherence rate was 
quite remarkable considering the challenges that other inves-
tigators typically face when accelerometer devices are used 
for brief periods to ascertain exercise participation (Dubbert 
et al 2002). The high adherence rate could be attributed to our 
weekly contact, but also that a majority of the subjects were 
retired and very conscientious in implementing routines to 
help them remember to wear the device. This ﬁ  nding should 
provide some measure of support to researchers to further 
explore the possible use of like devices to passively monitor 
and detect dynamic changes in patients’ physical functioning 
over time. 
Aside from the extraneous artifact that typically accompany 
accelerometry recordings, the variability in day-to-day physical 
activity was, to some degree expected, since previous reports 
described patients’ experiences of “good” and “bad” days. The 
ﬁ  ndings from two studies that used an accelerometer (Pitta 
et al 2005) and pedometer (Schonhofer et al 1997) for shorter 
monitoring periods conﬁ  rm our observations. The mean coef-
ﬁ  cient of variation for walking time in 18 patients with COPD 
over ﬁ  ve days was 28% ± 14% and was as high as 89% ± 35% 
with lying time. The degree of variability was not associated 
with disease severity or age (Pitta et al 2005). The report by International Journal of COPD 2006:1(4)  458
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Sandland and colleagues (2005) of no signiﬁ  cant differences in 
mean activity counts within subjects over a seven day window 
were probably reﬂ  ective of intra-individual variations. One 
group of investigators actually reported strikingly similar 
patterns of variability in daily self-reported health status over 
the course of a year for patients who were discharged from a 
hospital for AECOPD (Verbrugge et al 1989). The tremendous 
within-subjects variation in accelerometry-derived activity 
data may perhaps have signiﬁ  cant drawbacks for use, both as 
a reliable summary outcome measure from therapies and as 
a potential “marker” for early identiﬁ  cation of AECOPD or 
delayed functional recovery after an AECOPD . 
Though very preliminary, our ﬁ  ndings suggest that patients 
whose AECOPD are milder and are managed outside of a hospi-
tal did not have visible changes in their physical activity pattern 
before, during, or after their AECOPD episodes. Only one study 
presented in the form of an abstract actually measured physical 
activity in patients with COPD during AECOPD but regrettably, 
those AECOPD episodes, presumably more severe, were treated 
in a hospital (Pitta et al 2004). Patients were monitored on days 
2 and 7 of their hospitalization and 1 month after discharge 
for 12 hours using a tri-axial activity monitor worn on a belt 
with a second sensor attached to the leg. Unlike the RT3, the 
leg sensor provided a second positioning coordinate, allowing 
the device to differentiate between different positions. These 
patients walked signiﬁ  cantly less and spent more time in the 
lying position one month after discharge compared with stable, 
but unmatched COPD patients. Although matching can account 
for a limited number of factors that inﬂ  uence physical activity, 
comparisons of activity patterns should ideally be made using 
patients’ previous stable states which we have attempted to do. 
The work by Donaldson and colleagues (2005) partially supports 
our observations. They found that in a cohort of patients with 
COPD who were followed over an 8-year period had rapid 
recoveries from outpatient-treated AECOPD as measured by 
self-reports of time spent outdoors. It is important to note that 
our sample may not be characteristic of the general COPD 
population since three of the four unique AECOPD occurred 
in three subjects who were on a stable self-directed exercise 
regimen for more than 6 months prior to enrolling in the study. 
Also, the RT3, designed to be worn at the waist, does not have 
adequate speciﬁ  city in capturing decrements in certain other 
0.00
20.00
40.00
60.00
80.00
100.00
120.00
140.00
160.00
180.00
200.00
220.00
1 5 9 1 31 72 12 52 93 33 74 14 54 95 35 76 16 56 97 37 78 18 58 99 39 7 1 0 1 1 0 5 1 0 9 1 1 3
Days
A
v
e
r
a
g
e
 
V
M
U
/
M
i
n
u
t
e
SID8-No Exacerbations
Figure 1 Physical activity data for a 72-year old female subject who did not have an AECOPD during the study. The shaded band represents the 25th and 75th percentile. 
The dashed line shows the mean VMU/minute.
Abbreviations: AECOPD, acute exacerbations of chronic obstructive pulmonary disease; VMU, vector magnitude unit.International Journal of COPD 2006:1(4)  459
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potentially important ADL that may be negatively impacted 
by AECOPD. 
Conclusions
Our ﬁ  ndings suggest that patients with COPD will wear 
a pager-sized accelerometer that continuously tracks their 
physical activity over time, both during the stable state and 
with AECOPD episodes. The results of this study extend 
current knowledge regarding the comparable within-subjects 
variability in physical activity associated with outpatient-
treated AECOPD as in the stable state. A major caveat to 
our observations is that the sample was rather small with few 
events and we were not able to subject the data to rigorous 
statistical tests. However, we recommend additional work 
in this area, ﬁ  rst, identifying a simple device, unhampered 
by sophisticated data reduction and analysis algorithms that 
yield reliable ambulatory physical activity data and secondly, 
conduct of a larger study to document the natural pattern 
of physical activity across the illness continuum including 
periods of stable illness, during AECOPD, and recovery 
from these acute events. An understanding of these speciﬁ  c 
activity patterns might aid in the development of more timely 
and responsive interventions aimed at minimizing functional 
declines in this patient population.
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